InsiderTrades

Form 4 for EW Edwards Lifesciences

Accepted 2023-11-13 00:00:00 ET · period of report 2023-11-13 · accession 0001225208-23-010210 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-11-13 2023-11-13 EW BOBO DONALD E JR CVP, Strategy, Corp Development M - OptEx $36.75 +6,000 45.5K +15% +$220.5K
DM 2023-11-13 2023-11-13 EW BOBO DONALD E JR CVP, Strategy, Corp Development S - Sale+OE $65.30 -6,000 39.5K -13% -$391.8K
D 2023-11-13 2023-11-13 EW BOBO DONALD E JR CVP, Strategy, Corp Development M - OptEx $0.00 -6,000 56.0K -10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-11-13 M A 6,000 $36.75 45,502.69 D — —
2 Common Common Stock 2023-11-13 S D 2,300 $64.72 43,202.69 D — — (F2) This transaction was executed in multiple trades at prices ranging from $64.28 to $65.21. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2023-11-13 S D 3,700 $65.66 39,502.69 D — — (F3) This transaction was executed in multiple trades at prices ranging from $65.28 to $66.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
4 Derivative Employee Stock Option (Right to Acquire) 2023-11-13 M D 6,000 $0.00 56,000 D $36.75 · 2017-06-11 to 2024-05-10 6,000 Common Stock